Holtzer, R., Foley, F. W., Motl, R. W., Wagshul, M. E., Hernandez, M. E., Lipton, M. L., Picone, M. A., & Izzetoglu, M. (2024). Brain hemodynamic responses and fall prediction in older adults with multiple sclerosis. Multiple Sclerosis Journal, 30(13), 1664–1673. https://doi.org/10.1177/13524585241277400

Straus Farber, R., Walker, E. L., Diallo, F., Onomichi, K., Riley, C., Zhang, L., Zhu, W., De Jager, P. L., & Xia, Z. (2024). A randomized cross-over trial of prebiotics and probiotics in multiple sclerosis: Trial feasibility, supplement tolerability and symptom abatement. Multiple Sclerosis and Related Disorders, 89, 105762. https://doi.org/10.1016/j.msard.2024.105762

Juchem, C., Swanberg, K. M., Prinsen, H., & Pelletier, D. (2023). In vivo cortical glutathione response to oral fumarate therapy in relapsing-remitting multiple sclerosis: A single-arm open-label phase IV trial using 7-Tesla 1H MRS. NeuroImage: Clinical, 39, 103495. https://doi.org/10.1016/j.nicl.2023.103495

Okuda, D. T., Kantarci, O., Lebrun‐Frénay, C., Sormani, M. P., Azevedo, C. J., Bovis, F., Hua, L. H., Amezcua, L., Mowry, E. M., Hotermans, C., Mendoza, J., Walsh, J. S., von Hehn, C., Vargas, W. S., Donlon, S., Naismith, R. T., Okai, A., Pardo, G., Repovic, P., … Pelletier, D. (2022). Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome. Annals of Neurology, 93(3), 604–614. Portico. https://doi.org/10.1002/ana.26555

Ed‐driouch, C., Chéneau, F., Simon, F., Pasquier, G., Combès, B., Kerbrat, A., Le Page, E., Limou, S., Vince, N., Laplaud, D., Mars, F., Dumas, C., Edan, G., & Gourraud, P. (2022). Multiple sclerosis clinical decision support system based on projection to reference datasets. Annals of Clinical and Translational Neurology, 9(12), 1863–1873. Portico. https://doi.org/10.1002/acn3.51649

Ostkamp, P., Deffner, M., Schulte-Mecklenbeck, A., Wünsch, C., Lu, I.-N., Wu, G. F., Goelz, S., De Jager, P. L., Kuhlmann, T., Gross, C. C., Klotz, L., Meyer zu Hörste, G., Wiendl, H., Schneider-Hohendorf, T., & Schwab, N. (2022). A single-cell analysis framework allows for characterization of CSF leukocytes and their tissue of origin in multiple sclerosis. Science Translational Medicine, 14(673). https://doi.org/10.1126/scitranslmed.adc9778

Rotstein, D., Solomon, J. M., Sormani, M. P., Montalban, X., Ye, X. Y., Dababneh, D., Muccilli, A., Saab, G., & Shah, P. (2022). Association of NEDA-4 With No Long-term Disability Progression in Multiple Sclerosis and Comparison With NEDA-3. Neurology Neuroimmunology & Neuroinflammation, 9(6). https://doi.org/10.1212/nxi.0000000000200032

Rotstein, D., Solomon, J. M., Sormani, M. P., Montalban, X., Ye, X. Y., Dababneh, D., Muccilli, A., & Shah, P. (2022). Association of No Evidence of Disease Activity With No Long-term Disability Progression in Multiple Sclerosis. Neurology, 99(2). https://doi.org/10.1212/wnl.0000000000200549